{"id":"1b70f9823b15","type":"article","url":"https://hartvaat.nl/2021/08/01/fenotype-van-cpap-responders-bij-resistente-hypertensie-hiparco/","title":"Fenotype van CPAP-responders bij resistente hypertensie: HIPARCO","title_en":"Clinical Phenotype of Resistant Hypertension Responders to Continuous Positive Airway Pressure Treatment: Results From the HIPARCO Randomized Clinical Trial.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog","internist"],"tags":[],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.121.17364","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.121.17364","authors":["Miguel Angel Martinez-Garcia","Martino F Pengo"],"significance":5,"published":"2021-08-01","source_date":"2021-08-01","image":"","kennis":[],"congress":"","summary_en":"This HIPARCO analysis characterized the clinical phenotype of resistant hypertension patients who respond to CPAP therapy, identifying which obstructive sleep apnea patients benefit most from positive airway pressure for blood pressure control.","created":"2026-07-03T10:29:19Z","updated":"2026-07-03T13:28:27Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"HIPARCO resultaten naar het klinische fenotype van resistente hypertensie dat respondeert op CPAP.","abstract_original":""}